Pto Director S Estoppel Decision Ending Reexam Is Subject to Judicial Review
Contributed by Knobbe Martens. Originally published on Patexia; republished here as part of the LexDana archive.
Before Taranto, Chen, and Cunningham. Appeal from the United States District Court for the Eastern District of Virginia.
Summary: The Administrative Procedure Act (APA) permits judicial review of a Patent Office decision vacating an ex parte reexamination based on estoppel.
Alarm.com petitioned for inter partes review (IPR) of three patents owned by Vivint. The Patent Trial and Appeal Board (PTAB) upheld the patentability of the claims at issue, and the Federal Circuit affirmed. Subsequently, Alarm.com filed requests for ex parte reexamination of the same patents, based on “grounds that differed from the grounds it had presented in the IPRs.” The Director of the Patent and Trademark Office (PTO) vacated the ex parte reexamination proceedings based on IPR estoppel. Alarm.com sought review of the Director’s vacatur decision in district court under the APA. The district court dismissed Alarm.com’s complaint, finding that the statutory scheme for ex parte reexamination precluded judicial review of the Director’s decision.
The Federal Circuit found that the “text, statutory scheme, and legislative history pertaining to ex parte reexamination do not evince a fairly discernable intent to preclude judicial review” of the Director’s vacatur decision. Thus, the Federal Circuit reversed the dismissal.
Editor: Paul Stewart
Written by: Clint A. Saylor & Jeremy Anapol
More insights
Federal Circuit Affirms Invalidation of Patent for Lack of Enablement of Claims Directed to a Method of Treating a Patient with a Unit Dosage in Wyeth Llc v Astrazeneca Pharmaceuticals Lp
Written by : Eric Furman, Ph.D. and Ashley C. Morales Key Takeaway: Federal Circuit invalidates patent claims directed to a method for treating non-small cell lung cancer through administration of “a unit dosage” of an irreversible epidermal…
When About Becomes Indefinite Federal Circuit Provides Guidance for Life Science Patent Applications Regarding Limits of Approximation in Enviro Tech v Safe Foods
Written by : Jason J. Jardine and Kenneth O. Aruda, Ph.D. Key Takeaway: The term “about” remains useful in biotech and pharmaceutical claims, but only if the patent provides objective guidance about what the term means. Absent that guidance,…
When Any Patent Means No Patent Federal Circuit Reverses Non Specific Verdict
Written by : Brian C. Barnes and Sophia F. Zahn OLLNOVA TECHNOLOGIES LTD. v. ECOBEE TECHNOLOGIES ULC [OPINION] Before Chen , Cunningham, and Stark. Appeal from the United States District Court for the Eastern District of Texas. Summary : A verdict form…